10.11.2017 Views

Issue_4_2017

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

52<br />

analysis & control<br />

NUTRI-FACTS.org: Micronutrient research<br />

today<br />

Below you will find highlights from DSM’s highly informative NUTRI-FACTS website: keeping us upto-date<br />

with the latest developments in micronutrient research.<br />

from 2013–2020 resulting from<br />

lutein and R,R’-zeaxanthin<br />

supplementation.<br />

News: Supplementation<br />

with lutein and<br />

zeaxanthin could save<br />

¤6.2 billion in avoidable<br />

medical costs in Europe<br />

A new report from Frost & Sullivan<br />

suggests that daily<br />

supplementation with 10mg lutein<br />

and 2mg R,R’-zeaxanthin could<br />

save up to €6.2 billion in total<br />

medical costs resulting from agerelated<br />

macular degeneration<br />

(AMD) in Europe. To calculate<br />

healthcare cost savings, the<br />

analysis considered the prevalence<br />

of late-stage AMD in Europe, and<br />

the improvements in visual acuity<br />

for subjects using lutein and R,R’-<br />

zeaxanthin supplements versus<br />

placebo in a systematic review of<br />

clinical trials. They concluded that<br />

the observed 7% improvement in<br />

visual acuity would translate into<br />

fewer severe/late stage AMD<br />

case transitions and significant<br />

cost savings, including €6.2 billion<br />

in total saved costs per year, and a<br />

return of €5.01 for every €1.00<br />

invested in lutein and R,R’-<br />

zeaxanthin supplementation.<br />

The efficacy assumption on which<br />

the report was based is consistent<br />

with the 10% reduction in<br />

progression to late stage AMD<br />

that was observed in the Age-<br />

Related Eye Disease 2 (AREDS2)<br />

study conducted by the US<br />

National Institutes of Health. The<br />

reported healthcare cost savings<br />

are also consistent with a 2013<br />

Frost & Sullivan analysis on data<br />

from the United States. That study<br />

reported a US$7.42 billion<br />

cumulative projected cost savings<br />

Lutein and R,R’-zeaxanthin, two<br />

carotenoids found in green<br />

vegetables, are known for their<br />

antioxidant activity and are found<br />

in the retina of the eye. They are<br />

concentrated in the macula, which<br />

is colloquially known as the yellow<br />

spot. In fact, the term ‘lutein’ is<br />

derived from the Latin word for<br />

yellow. Because intake of green<br />

vegetables is low in many<br />

developed countries, daily intake<br />

of total lutein and zeaxanthin is<br />

typically about 1–2mg/day, far<br />

short of the beneficial amount in<br />

the above-referenced study.<br />

Healthcare costs aside, a price<br />

can’t be put on saving the eyesight<br />

of an individual. Increasing<br />

consumption of green vegetables,<br />

or consuming dietary supplements<br />

containing ‘free’ (unesterified)<br />

lutein and R,R’-zeaxanthin can<br />

help achieve the recommended<br />

levels of intake, a proactive step<br />

toward increasing macular pigment<br />

levels and supporting optimal eye<br />

health.<br />

www.foodmagazine.eu.com issue four | <strong>2017</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!